Business Context and Reporting Period
This Form 8-K filing by Pavmed Inc. (PAVM) covers the event date of July 29, 2025. The report addresses a regulatory notification from the Nasdaq Stock Market regarding the company's compliance with listing standards.
Key Financial Metrics
The filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on corporate governance and listing status.
Material Changes
The primary material event is the extension of the compliance period for the company's stock listing:
- Initial Deficiency: On January 23, 2025, Nasdaq notified Pavmed that its closing bid price had been below the $1.00 minimum requirement for 30 consecutive business days.
- Initial Period Expiration: The company failed to regain compliance within the initial 180-day period ending July 22, 2025.
- Extension Granted: Nasdaq has granted an additional 180 calendar days (until January 19, 2026) to regain compliance.
- Compliance Requirement: To maintain listing, the closing bid price must be at least $1.00 per share for a minimum of 10 consecutive business days during this new period.
Outlook, Risks, and Management Commentary
Management Commentary: The company intends to consider all available options to regain compliance with Nasdaq listing standards.
Current Status: The notification has no immediate effect on the listing; the common stock will continue to trade uninterrupted under the symbol "PAVM" on the Nasdaq Capital Market.
Risks: If the company fails to meet the $1.00 bid price requirement for 10 consecutive days by January 19, 2026, it faces potential delisting from the Nasdaq Stock Market.
Investor Verification Checklist
- Verify the current trading price of PAVM relative to the $1.00 threshold.
- Monitor the company's stock price for 10 consecutive business days to assess progress toward compliance.
- Review future filings for announcements of reverse stock splits or other corporate actions intended to increase the share price.
- Confirm the final deadline of January 19, 2026, for regaining compliance.